EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 117 filers reported holding EPIZYME INC in Q3 2021. The put-call ratio across all filers is 1.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $203,000 | -45.7% | 24,448 | -43.0% | 0.02% | -50.0% |
| Q1 2021 | $374,000 | -35.1% | 42,895 | -11.1% | 0.03% | -8.1% |
| Q3 2020 | $576,000 | +78.9% | 48,260 | +54.7% | 0.04% | +32.1% |
| Q3 2019 | $322,000 | -1.8% | 31,190 | +28.7% | 0.03% | +21.7% |
| Q2 2018 | $328,000 | +52.6% | 24,228 | +41.3% | 0.02% | -4.2% |
| Q4 2017 | $215,000 | -60.6% | 17,151 | -40.0% | 0.02% | -82.5% |
| Q3 2017 | $545,000 | +196.2% | 28,593 | +134.3% | 0.14% | +174.0% |
| Q2 2017 | $184,000 | -52.5% | 12,206 | -67.7% | 0.05% | -2.0% |
| Q2 2016 | $387,000 | -31.4% | 37,801 | +7.3% | 0.05% | +2.0% |
| Q4 2015 | $564,000 | +99.3% | 35,219 | +198.5% | 0.05% | +56.2% |
| Q2 2015 | $283,000 | -73.6% | 11,800 | -79.3% | 0.03% | -70.6% |
| Q1 2015 | $1,072,000 | +22.0% | 57,124 | +22.5% | 0.11% | -29.7% |
| Q4 2014 | $879,000 | – | 46,613 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |